Translating today's science into tomorrow's treatments

IBD BioResource

IBD_BioResource_logoWe will be launching the new UK-wide IBD BioResource in early November 2015 – aiming to have our first recruits in by the end of the year and with national roll-out through 2016. This temporary website will be substantially upgraded and updated in early 2016 so please return then for more details about the IBD BioResource when much more information will be available on what the IBD BioResource is doing and how you can help us to advance research in Crohn’s disease and ulcerative colitis.

Recent years have seen major advances in understanding the causes of Crohn’s and colitis. This particularly relates to their genetic basis, and how genetic variants affect the immune system of people who go on to develop IBD. Much of this work has been lead by our UK IBD genetics consortium. The key challenge now is to translate this new knowledge into new treatments, and use it as a platform to drive towards a cure for IBD. This is where the IBD BioResource comes in! – allowing scientists and researchers to access groups of patients with IBD based on their known genetic make-up, so that they can ask very focused questions relating to disease mechanisms and potential new treatments.

What next?

For Patients

If you have Crohn's disease or ulcerative colitis and would be willing to participate in a large-scale genetic analysis and in future IBD research then please let us know. Recruitment will happen through your local hospital clinic. It just needs you to provide consent, fill in a questionnaire and provide a blood sample. For more details please contact us at ibd@bioresource.nihr.ac.uk

For clinical teams

If you and your team are interested in helping us to assemble the IBD Bioresource, with support from the CRN and from the BRC, then please contact us at ibd@bioresource.nihr.ac.uk

We will help you get set up!

For research teams

We hope to have recruited several thousand volunteers with Crohn's or colitis by mid 2016 and a total of 25,000 patients by 2017, to help push IBD research much faster than has been possible to date. Individuals will be recallable by genotype or sub-phenotype for sampling or participation in research studies , all organised through the NIHR Bioresource. If you work in science or industry and would like to access this resource please contact us through ibd@bioresource.nihr.ac.uk

Crohn's and Colitis
Medical Research Council
Sanger Institute